Imunon (IMNN) Assets (2010 - 2026)
Imunon's (IMNN) quarterly Assets came in at $8.0 million in Q1 2026, up 16.86% YoY from $6.9 million in Q1 2025, and down 34.74% on a QoQ basis from $12.3 million in Q4 2025.
Imunon (IMNN) Assets (2010 - 2026) Analysis & Trends
Imunon (IMNN) has 17 years of Assets data on file, last reported at $8.0 million in Q1 2026.
- Quarterly Assets rose 16.86% year-over-year to $8.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.0 million (up 16.86% YoY) and the FY2025 annual result came in at $12.3 million, up 26.46% from the prior year.
- Assets eased to $8.0 million in Q1 2026, from $12.3 million in the prior quarter.
- In the past five years, Assets ranged from a high of $65.3 million in Q2 2022 to a low of $6.9 million in Q1 2025.
- A 5-year average of $26.9 million and a median of $18.1 million in 2023 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets plunged 66.26% — and 2025, when it advanced 26.46%.
- Tracing IMNN's Assets over 5 years: stood at $44.0 million in 2022, then slumped by 50.16% to $21.9 million in 2023, then plunged by 55.67% to $9.7 million in 2024, then increased by 26.46% to $12.3 million in 2025, then slumped by 34.74% to $8.0 million in 2026.
- The last three Assets figures came in at $8.0 million (Q1 2026), $12.3 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Imunon | 8.42 Mn | 8.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.02 Mn |
| Dec 31, 2025 | 12.29 Mn |
| Sep 30, 2025 | 8.99 Mn |
| Jun 30, 2025 | 8.79 Mn |
| Mar 31, 2025 | 6.86 Mn |
| Dec 31, 2024 | 9.72 Mn |
| Jun 30, 2024 | 9.69 Mn |
| Mar 31, 2024 | 14.32 Mn |
| Dec 31, 2023 | 21.92 Mn |
| Sep 30, 2023 | 24.65 Mn |
| Jun 30, 2023 | 28.72 Mn |
| Mar 31, 2023 | 42.11 Mn |
| Dec 31, 2022 | 43.98 Mn |
| Sep 30, 2022 | 60.53 Mn |
| Jun 30, 2022 | 65.33 Mn |
| Mar 31, 2022 | 64.34 Mn |
| Dec 31, 2021 | 74.05 Mn |
| Sep 30, 2021 | 79.47 Mn |
| Jun 30, 2021 | 83.01 Mn |
| Mar 31, 2021 | 73.04 Mn |